(Q33487821)

English

Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

phase I clinical trial

0 references

anti-retroviral agent

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Moyle GJ

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Youle M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Higgs C

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Monaghan J

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Prince W

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Chapman S

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Clendeninn N

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Nelson MR

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

736-743

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04814.X

21 January 2018

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04814.X

21 January 2018

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04814.X

21 January 2018

To sequence or not to sequence?

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04814.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04814.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1998.TB04814.X

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33487821&oldid=1951786436"